<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Andrade C</submitter><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><pagination>e2720</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6667909</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(1)</volume><pubmed_abstract>Single chain variable fragment-IgGs (scFv-IgG) are a class of bispecific antibodies consisting of two single chain variable fragments (scFv) that are fused to an intact IgG molecule. A common trend observed for expression of scFv-IgGs in mammalian cell culture is a higher level of aggregates (10%-30%) compared to mAbs, which results in lower purification yields in order to meet product quality targets. Furthermore, the high aggregate levels also pose robustness risks to a conventional mAb three column platform purification process which uses only the polishing steps (e.g., cation exchange chromatography [CEX]) for aggregate removal. Protein A chromatography with pH gradient elution, high performance tangential flow filtration (HP-TFF) and calcium phosphate precipitation were evaluated at t</pubmed_abstract><journal>Biotechnology progress</journal><pubmed_title>An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.</pubmed_title><pmcid>PMC6667909</pmcid><funding_grant_id>203023/2014‐5</funding_grant_id><pubmed_authors>Arnold L</pubmed_authors><pubmed_authors>Chung WK</pubmed_authors><pubmed_authors>Andrade C</pubmed_authors><pubmed_authors>Hunter A</pubmed_authors><pubmed_authors>Tang A</pubmed_authors><pubmed_authors>Motabar D</pubmed_authors><pubmed_authors>Aspelund M</pubmed_authors></additional><is_claimable>false</is_claimable><name>An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.</name><description>Single chain variable fragment-IgGs (scFv-IgG) are a class of bispecific antibodies consisting of two single chain variable fragments (scFv) that are fused to an intact IgG molecule. A common trend observed for expression of scFv-IgGs in mammalian cell culture is a higher level of aggregates (10%-30%) compared to mAbs, which results in lower purification yields in order to meet product quality targets. Furthermore, the high aggregate levels also pose robustness risks to a conventional mAb three column platform purification process which uses only the polishing steps (e.g., cation exchange chromatography [CEX]) for aggregate removal. Protein A chromatography with pH gradient elution, high performance tangential flow filtration (HP-TFF) and calcium phosphate precipitation were evaluated at t</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-04-04T22:08:51.887Z</modification><creation>2019-08-28T07:01:41Z</creation></dates><accession>S-EPMC6667909</accession><cross_references><pubmed>30298991</pubmed><doi>10.1002/btpr.2720</doi></cross_references></HashMap>